Vanda Reports Positive Results for Tradipitant in...
Category : Clinical Trial Update 18 November 2025Vanda Pharmaceuticals Inc. announced positive topline results from a randomized, controlled clinical...
Newsletter - All News
Newsletter- All News is a comprehensive section of updated news and current trends, specifically curated to keep clinical trials, including breakthroughs in drug research, regulatory approvals, and advancements in study methodologies. Our news covers key trends in trial designs, patient recruitment strategies, and cutting-edge technologies shaping the future of clinical research
Resolve Therapeutics to Present Platform and Clini...
Category : Clinical Trial Update 18 November 2025Resolve Therapeutics, a mid-stage biopharmaceutical company developing non-immunosuppressive therapi...
TransCon CNP Shows Promising Week 52 Results in Ac...
Category : Clinical Trial Update 18 November 2025Ascendis Pharma has shared pivotal Week 52 results from its ApproaCH Trial evaluating once-weekly Tr...
Bristol Myers Squibb & Johnson & Johnson Halt Phas...
Category : Clinical Trial Update 17 November 2025Bristol Myers Squibb (BMS) and Johnson & Johnson have jointly decided to stop the Phase 3 Librex...
EMA Recommends Approval of Teizeild (Teplizumab) t...
Category : Clinical Trial Update 17 November 2025The European Medicines Agency (EMA) has recommended granting EU-wide marketing authorisation for Tei...
Latest Newsletter Post
-
TransCon CNP Shows Promising Week 5..
18 November 2025
-
Resolve Therapeutics to Present Pla..
18 November 2025
-
Vanda Reports Positive Results for..
18 November 2025
-
Akeso Receives NMPA Approval to Beg..
17 November 2025
-
EMA Recommends Approval of Teizeild..
17 November 2025
Subscribe to Our Newsletter!
C-89, Sector-65 Noida-U.P. 201301 (India)
Phone: +91-120-6631301-361
Mobile: +91-9990237670
Customer Care: 18004190155
Email: info@lifescienceintellipedia.com
Email: sales@lifescienceintellipedia.com